ArticleFrontiers in nuclear medicine2026
Radiopharmacy services in South African academic hospitals: implications for planning radiopharmacy services in Africa.
Article in Frontiers in nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nuclear medicine (NM) is being embraced by undeveloped countries as a specialty. Due to the high costs involved in establishing new NM and radiopharmacy centres, proper planning is essential. This study describes the pattern of radiopharmacy services and staffing in NM departments in South African Academic hospitals (SAAHs); which can aid planning of new NM and radiopharmacy centres in similar settings. Methods: The study was retrospective, descriptive, and quantitative. An anonymized questionnaire was sent via Survey Monkey® to the nine SAAHs to determine nuclear medicine patient numbers by scan type, identify cameras, equipment, staffing levels, commonly used radiopharmaceuticals, and define the basic requirements for establishing new facilities. Results: The response rate was 78% (7/9 hospitals). Average number of NM patients seen per hospital was 7,040 for 2022. All hospitals had SPECT-CT cameras; six had PET-CT cameras and one referred PET patients to a private hospital. All hospitals had NM physicians (range 2-13, average 5) and at least one medical physicist (range 1-4). Only two hospitals had radiopharmacists (only one in each). Conclusion: To promote optimal patient services and support research in SAAHs, norms must be developed that are applicable to Africa. Appropriate staff quotas and equipment are required for the African setting to promote optimal use of radiopharmaceuticals and enable NMs to operate to their full potential. Key things to help in planning and establishing new radiopharmacy centers include; adopting centralized radiopharmaceutical production and aligning staffing with international guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.